Your browser doesn't support javascript.
loading
A phase I clinical trial of weekly oral topotecan for relapsed small cell lung cancer.
Agelaki, S; Kontopodis, E; Kotsakis, A; Chandrinos, V; Bompolaki, I; Zafeiriou, Zeta; Papadimitraki, E; Stoltidis, D; Kalbakis, K; Georgoulias, V.
Affiliation
  • Agelaki S; Department of Medical Oncology, University General Hospital of Heraklion, PO Box 1352, 71110, Heraklion, Crete, Greece. agelaki@med.uoc.gr
Cancer Chemother Pharmacol ; 72(1): 45-51, 2013 Jul.
Article in En | MEDLINE | ID: mdl-23604531
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Palliative Care / Topotecan / Small Cell Lung Carcinoma / Topoisomerase I Inhibitors / Lung Neoplasms Type of study: Clinical_trials Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Cancer Chemother Pharmacol Year: 2013 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Palliative Care / Topotecan / Small Cell Lung Carcinoma / Topoisomerase I Inhibitors / Lung Neoplasms Type of study: Clinical_trials Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Cancer Chemother Pharmacol Year: 2013 Document type: Article Affiliation country: Country of publication: